CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 109 enrolled
Drug / intervention
alcoholdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00295334
NCT00295334Phase 2Completed
CompareCT.gov

Moderate Alcohol Intake Among Patients With Type 2 Diabetes

Iris Shai·interventional·Posted Feb 23, 2006·Updated Jun 24, 2025

In Brief

A Phase 2 clinical trial evaluating alcohol for Type 2 Diabetes. Completed, enrolled 109 participants.

Detailed Summary

Our specific aim is to explore the effect of moderate alcohol intake on parameters of glycemic index and lipid profile among patients with type 2 diabetes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes
Countries--
CollaboratorsThe Israeli Diabetes Research Group, Hadassah Medical Organization, Soroka University Medical Center, Julio Vainstein, Wolfson Medical Center, Holon, Israel, Tishbi Wines, Israel and Admiral Wine Imports, US, Harvard University

Timeline

Phase 2CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 23, 2006
Enrollment StartJun 1, 2010
Primary CompletionMay 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 20.4 years ago

Interventions

alcoholdrug